Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2026-05-18 @ 7:03 AM
Study NCT ID:
NCT00117533
Status:
UNKNOWN
Last Update Posted:
2006-05-25
First Post:
2005-06-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta
Sponsor:
National Taiwan University Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
930904
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None